Skip to main content
. 2021 Apr 16;6(16):10897–10909. doi: 10.1021/acsomega.1c00654

Table 4. Effect of Acute, Subacute, and Teratogenicity on Hematological Parametersa.

        subacute toxicity
        5 mg/kg
10 mg/kg
20 mg/kg
40 mg/kg
hematology parameters control acute oral toxicity terato-genicity M F M F M F M F
WBC’s 3.7 ± 0.12 13.8 ± 0.1* 12.8 ± 0.2* 3.6 ± 0.42 6.8 ± 0.2* 5.2 ± 0.2* 5.2 ± 0.1* 4.0 ± 0.3 8.0 ± 0.3* 6.0 ± 0.1* 8.8 ± 0.2*
RBC’s 5.95 ± 0.32 6.67 ± 0.6 5.65 ± 1.1 6.12 ± 0.3 5.92 ± 1.1 6.13 ± 0.1 5.11 ± 1.2 6.94 ± 1.2 6.53 ± 2.1 5.89 ± 1.1 6.55 ± 1.3
platelets 817 ± 0.14 603 ± 0.52 800 ± 0.2 659 ± 0.4 750 ± 0.2 615 ± 0.21 750 ± 0.3 817 ± 0.12 888 ± 0.1 650 ± 0.32 806 ± 0.3
Hb 12.0 ± 1.2 12.8 ± 0.3 12.0 ± 0.14 12.9 ± 0.1 12.7 ± 0.1 13.0 ± 0.1 11.2 ± 0.1 12.9 ± 0.1 12.5 ± 0.1 12.6 ± 1.1 12.9 ± 0.1
LYM (×103/μL) 3.1 ± 1.4 7.0 ± 2.1* 10.9 ± 1.1* 2.9 ± 1.0 4.6 ± 1.0 3.0 ± 1.1 3.0 ± 1.1 5.8 ± 0.9 4.3 ± 1.0 4.8 ± 1.0 5.1 ± 1.1
MID (×103/μL) 0.4 ± 1.3 5.9 ± 1.3 1.5 ± 0.5 0.7 ± 0.62 0.8 ± 0.3 0.8 ± 0.7 0.8 ± 0.5 6.3 ± 0.5 1.1 ± 0.6 5.4 ± 0.6 1.1 ± 0.6
GRA (×103/μL) 0.1 ± 0.02 0.8 ± 0.1* 0.4 ± 0.1 1.0 ± 0.1* 0.4 ± 0.0 0.4 ± 0.12 0.4 ± 0.2 0.5 ± 0.13 0.6 ± 0.6 0.3 ± 0.1 0.6 ± 0.1
MCH (pg) 20.30 ± 0.1 19.1 ± 0.8 19.6 ± 0.2 21.0 ± 0.3 21.6 ± 0.1 21.2 ± 0.2 22 ± 0.2 20.1 ± 0.2 20.6 ± 0.2 18 ± 0.12 19.9 ± 0.2
MCHC (g/dL) 36.5 ± 0.96 35.8 ± 0.2 33.5 ± 0.8 35.5 ± 0.7 34.1 ± 0.8 36.2 ± 0.8 36.1 ± 0.8 34.9 ± 0.8 35.9 ± 0.9 34.4 ± 0.7 35.1 ± 0.7
MCV (fl) 55.4 ± 1.2 53.6 ± 1.0 58.6 ± 0.2 59.1 ± 0.2 53.3 ± 0.1 58.6 ± 0.1 51.0 ± 0.2 57.7 ± 0.1 57.5 ± 0.1 52 ± 0.2 56.7 ± 0.2
HCT (%) 33.0 ± 3.2 36.2 ± 2.1 33.1 ± 1.2 36.2 ± 1.3 37.5 ± 1.2 35.6 ± 1.5 31.2 ± 1.5 22.7 ± 1.1 37.5 ± 1.1 30.9 ± 2.4 37.1 ± 1.2
a

The data are represented as mean ± SEM with n = 5 for acute toxicity, n = 10 for teratogenicity, and n = 10 for subacute toxicity studies. *P < 0.05 was the increased level of significance compared to the control. M = male and F = female.